ADMA Biologics Inc ADMA:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/05/22 EDT
2.70quote price arrow up+0.02 (+0.75%)
Volume
2,081,528
52 week range
1.01 - 2.92
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.70
  • 52 Week High2.92
  • 52 Week High Date09/08/22
  • 52 Week Low1.01
  • 52 Week Low Date10/21/21

Key Stats

  • Market Cap530.17M
  • Shares Out196.36M
  • 10 Day Average Volume3.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.98
  • YTD % Change91.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.70
  • 52 Week High2.92
  • 52 Week High Date09/08/22
  • 52 Week Low1.01
  • 52 Week Low Date10/21/21
  • Market Cap530.17M
  • Shares Out196.36M
  • 10 Day Average Volume3.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.98
  • YTD % Change91.49

RATIOS/PROFITABILITY

  • EPS (TTM)-0.42
  • P/E (TTM)-6.40
  • Fwd P/E (NTM)-10.67
  • EBITDA (TTM)-45.272M
  • ROE (TTM)-64.72%
  • Revenue (TTM)110.07M
  • Gross Margin (TTM)13.93%
  • Net Margin (TTM)-66.44%
  • Debt To Equity (MRQ)122.21%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ADMA Biologics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ADMA Biologics, Inc. is a biopharmaceutical company. It develops, manufactures, and markets specialty plasma-based biologics for the treatment and prevention of infectious diseases. It is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its patients include immune-compromised individuals who suffer from an underlying immune deficiency disorder and immune-suppressed for medical reasons. Its product candidates include BIVIGAM, an...
Jerrold Grossman
Vice Chairman of the Board, Co-Founder
Steven Elms
Independent Chairman of the Board
Adam Grossman
President, Chief Executive Officer, Co-Founder, Director
Brian Lenz
Chief Financial Officer, Executive Vice President
Address
C/O Adma Biologics
Inc., 465 State Route 17
Ramsey, NJ
07446
United States

Top Peers

SYMBOLLASTCHG%CHG
HRTX
Heron Therapeutics Inc
4.47-0.20-4.28%
EOLS
Evolus Inc
8.85+0.05+0.57%
PGEN
Precigen Inc
2.26+0.04+1.80%
ADCT
ADC Therapeutics SA
5.10-0.14-2.67%
NKTR
Nektar Therapeutics
3.36+0.01+0.30%